Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.41 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.41 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.41 |
| ▸ | HRH1 known ✓ | P35367 | 1/20 | 0.41 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.41 |
| ▸ | GBA1 known ✓ | P04062 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tartaric Acid SCHEMBL30771976 | 1.00 | TSHR (0.67) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL27981116 | 0.97 | TSHR (0.62) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL27681736 | 0.97 | TSHR (0.62) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL7337182 | 0.97 | TSHR (0.62) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL27681738 | 0.97 | TSHR (0.62) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL6560274 | 0.94 | TSHR (0.59) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL18987140 | 0.90 | TSHR (0.71) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL2158124 | 0.87 | TSHR (0.67) | TSHRCYP2C9PDE4ATP53CHRM1 | |
| Tartaric Acid SCHEMBL30628132 | 0.84 | TSHR (0.62) | TSHRCYP2C9PDE4ATP53CHRM1 | |
| Cadaverine Tartrate SCHEMBL5874705 | 0.84 | TSHR (0.62) | TSHRCYP2C9PDE4ATP53CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115466530-B | Modified silicon dioxide crystal face agent and preparation method and application thereof | 武汉工程大学 | 2023-10-27 | — | — | CN | claimed |
| CN-114424823-B | A soft capsule containing natural extract for reducing blood lipid and its preparation method | 江苏海王健康生物科技有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-115466530-A | Modified silicon dioxide crystal face agent and preparation method and application thereof | 武汉工程大学 | 2022-12-13 | — | — | CN | claimed |
| CN-115260043-A | Synthesis method of meta-hydroxylamine bitartrate | 海南长春花药业有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-113171353-B | Trimebutine maleate tablet | 海南普利制药股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-114956738-A | C35 underwater undispersed concrete and preparation method thereof | 陕西百固建材有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-114424823-A | A soft capsule containing natural extract for reducing blood lipid, and its preparation method | 江苏海王健康生物科技有限公司 | 2022-05-03 | — | — | CN | claimed |
| CN-111233069-B | Permeable reactive barrier active material and preparation method thereof | 郑州大学 | 2022-03-11 | — | — | CN | claimed |
| CN-113171353-A | Trimebutine maleate tablet | 海南普利制药股份有限公司 | 2021-07-27 | — | — | CN | claimed |
| CN-111233069-A | Permeable reactive barrier active material and preparation method thereof | 郑州大学 | 2020-06-05 | — | — | CN | claimed |
| CN-109306025-A | A method of extracting pectin from Citrus peel | 赵义平 | 2019-02-05 | — | — | CN | claimed |
| CN-107892693-A | A kind of preparation method of ticagrelor | 安徽诺全药业有限公司 | 2018-04-10 | — | — | CN | claimed |
| CN-104262314-B | Black rice anthocyanin preparation technology | 长春海涛天然色素有限公司 | 2016-08-17 | — | — | CN | claimed |
| CN-103275031-A | Method for preparing optically pure fosaprepitant intermediate | TAIZHOU JINHONG MEDICINE SCIENCE & TECHNOLOGY CO LTD | 2013-09-04 | — | — | CN | claimed |
| CN-102151243-B | Paclitaxel injection and preparation method thereof | CISEN PHARMACEUTICAL CO LTD | 2013-06-05 | — | — | CN | claimed |
| CN-102151243-A | Paclitaxel injection and preparation method thereof | SHANDONG LUKANG CISEN PHARMACEUTICAL CO LTD | 2011-08-17 | — | — | CN | claimed |
| CN-102065689-A | RHO-kinase inhibitor compounds | INSPIRE PHARMACEUTICALS INC | 2011-05-18 | — | — | CN | claimed |
| CN-119684315-B | Crystal form of benzothiophene substituted fused ring compound and preparation method thereof | 苏州盛迪亚生物医药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-1432017-A | Novel triazolopyrimidine compounds | ASTRAZENECA AB (SE) | 2003-07-23 | — | — | CN | disclosed |
| CN-1345727-A | Aqueous soluble steroid compound alkaloid salt, preparation process and medicinal composition containing same | SHANDONG LUYE PHARM CO LTD (CN) | 2002-04-24 | — | — | CN | disclosed |